
Lucy NORRIS
@lucynortcd
Scientist at Trinity College Dublin. Interested in thrombosis in cancer, pregnancy and women's health. Co-editor in chief Thrombosis Update. Opinions my own.
ID: 926592712979238912
03-11-2017 23:31:32
2,2K Tweet
556 Followers
618 Following


Well done Elzahra Ibrahim from Trinity St James's Cancer Institute representing Irish Doctors at the World Gynecologic Oncology Day event ESGO ENGAGe.ESGO #esgo2025 in #Rome Great to see our #DipOrDance #INGO campaign represented Miriam O'Callaghan The Reputations Agency


More patient-led research from the PCC CancerTrialsIreland 🌈 led by @MiriamStaunton. Please share

Cancer-associated thrombosis is not only about venous events. Patients with cancer and no prior strokes have a 1.5 ⬆️risk of ischemic stroke compared to those without cancer. ⬆️risk with certain cancer types sciencedirect.com/science/articl… JTH CanVECTOR Network Thrombosis Canada


Is there a better way to predict pulmonary thromboembolism #PTE mortality? 🤔 New research in Thrombosis Update says RV/LV ratio on #CTPA might be the key. Find out how: sciencedirect.com/science/articl… Lucy NORRIS #TruJournal



Mahé Isabelle NEJM INNOVTE INVENT-VTE Laurent Bertoletti Francis Couturaud manuel monreal Ander Cohen ISTH Peter Verhamme Philippe Girard Elegant editorial on the importance of capturing and reporting bleeding events in trials assessing anticoagulation in patients with cancer by Prof. Simon Noble in NEJM nejm.org/doi/full/10.10…



Safe #PE treatment for #cancer patients? Ultrasound-guided thrombolysis #CDT shows promise! New study in Thrombosis Update found similar low bleeding rates in cancer & non-cancer patients. Read more here: sciencedirect.com/science/articl… Lucy NORRIS #TruJournal


🚨New publication alert!🚨 If you're interested in ovarian cancer metastasis or liquid biopsies, check out my latest paper in the European Journal of Surgical Oncology! 🔗sciencedirect.com/science/articl…🔗 Huge thanks to the patients, families, & staff St James's Hospital 🩸✨



It has been unclear why cancer patients with CH have worse outcomes. Our work published NEJM uncovers that Tumor infiltrating CH (TI-CH) has a direct role in immune remodelling of the TME with implications for tumor progression & treatment response. Memorial Sloan Kettering Cancer Center The Crick

Deeply honoured to be appointed Commissioner on first ever The Lancet Commission on Ovarian Cancer. Led by global experts, and with women with #ovariancancer at the heart of its work, the Commission aims to transform the future of this disease. Excellent first mtg in Nice!





